[1]
Yao, X.H.; Li, T.Y.; He, Z.C.; Ping, Y.F.; Liu, H.W.; Yu, S.C.; Mou, H.M.; Wang, L.H.; Zhang, H.R.; Fu, W.J.; Luo, T.; Liu, F.; Chen, C.; Xiao, H.L.; Guo, H.T.; Lin, S.; Xiang, D.F.; Shi, Y.; Li, Q.R.; Huang, X.; Cui, Y.; Liu, X.Z.; Tang, W.; Pan, P.F.; Huang, X.Q.; Ding, Y.Q.; Bian, X.W. A pathological report of three COVID-19 cases by minimally invasive autopsies Zhonghua bing li xue za zhi = Chinese J. Pathalogy, 2020, 49E9
[4]
Xie, X.; Zhong, Z.; Zhao, W.; Zheng, C.; Wang, F.; Liu, J. Chest CT for typical 2019-nCoV pneumonia: Relationship to negative rt-pcr testing. Radiology, 2020, 296(2), E41-E45.
[5]
Mao, L.; Jin, H.; Wang, M.; Hu, Y.; Chen, S.; He, Q.; Chang, J.; Hong, C.; Zhou, Y.; Wang, D.; Miao, X.; Li, Y.; Hu, B. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan. JAMA Neurol., 2020, 77(6), 683-690.
[8]
Depoux, A.; Martin, S.; Karafillakis, E.; Preet, R.; Wilder-Smith, A.; Larson, H. The pandemic of social media panic travels faster than the COVID-19 outbreak. J. Travel Med., 2020, 27(3)
[10]
Zhang, B.; Zhou, X.; Qiu, Y.; Song, Y.; Feng, F.; Feng, J.; Song, Q.; Jia, Q.; Wang, J. Clinical characteristics of 82 death cases with COVID-19. medRxiv preprint, 2020, 15(7), e0235458..
[11]
Huang, Y.; Yang, R.; Xu, Y.; Gong, P. Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan. medRxiv preprint,. 2020.
[12]
Clinical strategies for prevention and treatment neurologist consensus editorial group, corona.c., 2019 clinical prevention and treatment of coronavirus disease (covid-19). Chin. J. Neurol., 2020, e001-e001.
[18]
Chang, D.; Liu, M.G.; Wei, L.; Xie, L.X.; Zhu, G.F.; Cruz, C.S.; Sharm, L. Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside wuhan. JAMA, 2020, 323(11), 1092-1093.
[22]
Pan, F.; Ye, T.; Sun, P.; Gui, S.; Liang, B.; Li, L.; Zheng, D.; Wang, J.; Hesketh, R.L.; Yang, L.; Zheng, C. Time course of lung changes on chest ct during recovery from 2019 novel coronavirus (COVID-19) Pneumonia. Radiology, 2020, 295(3), 715-721.
[28]
AC. W.; YJ, P.; MA, T. A W, AT M, D V. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell, 2020, 181(2), 281-292.e6.
[29]
Yan, R.H.; Zhang, Y.Y.; Li, Y.N.; Xia, L.; Guo, Y.Y.; Zhou, Q. Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2. Science, N.Y. 2020, 367(6485), 1444-1448.
[39]
Li, Z.; Ge, J.; Yang, M.; Feng, J.; Qiao, M.; Jiang, R.; Bi, J.; Zhan, G.; Xu, X.; Wang, L.; Zhou, Q.; Zhou, C.; Pan, Y.; Liu, S.; Zhang, H.; Yang, J.; Zhu, B.; Hu, Y.; Hashimoto, K.; Jia, Y.; Wang, H.; Wang, R.; Liu, C.; Yang, C. Vicarious traumatization in the general public, members, and non-members of medical teams aiding in COVID-19 control. Brain Behav. Immun., 2020, 88, 916-919.